News from Zyme and the companies we work with.
SynGenSys introduces Liver.SET synthetic promoter library for liver-specific gene expression for in vivo gene therapies
Validated, tissue-specific library enables customisable and controllable liver-targeted gene expression with high specificity and minimal off-target activity in muscle tissue Sheffield, UK, 05 February 2026: SynGenSys, a biotechnology company designing [...]
iXCells Biotechnologies and Rosebud Biosciences Partner to Advance Organoid-Based Models for Rare Diseases
Expansion of iXCells’ iPSCore platform with integration of 3D human organoid expertise will enable evaluation of drug toxicity and tissue-specific responses Responds to growing demand for scalable, patient-relevant human models [...]
Vortex Biotech Opens New State-of-the-Art Laboratory at Manchester Science Park
Expansion accelerates the development of its non-invasive cancer diagnostic solutions Manchester, UK – 27 January 2026 – Vortex Biotech Holdings Limited has announced the opening of its advanced laboratory facilities [...]
ProImmune Introduces Mastering Immunity 2026 – Shanghai Symposium to Address Key Immunogenicity Challenges
Symposium brings together global leaders in immunogenicity to connect with China’s rapidly evolving pharmaceutical development landscape Speakers include thought leaders in biotherapeutics, complex peptide drug developers, and regulatory authorities In-person [...]
SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT’s firefly platform
Automated Twist NGS library preparation workflows available on SPT Labtech’s firefly platform via the firefly cloud Validated methods support Twist FlexPrep™ UHT and Enzymatic Fragmentation Kit 2.0, enabling higher throughput [...]
Axol Bioscience raises $2.8M to advance US expansion and product development
Financing led by US life sciences investor, BroadOak Capital Partners Investment to support expansion of US operations, product development, and cell manufacturing scale-up Cambridge / Edinburgh, UK, 13th January 2026: [...]
Optibrium Appoints Dr Nathan Brown as Director of Science
Newly created role underscores commitment to customer-driven research and scientific excellence CAMBRIDGE, UK, 13 January 2026 – Optibrium, a leading developer of software and AI solutions for molecular design, today [...]
Nuclera extends Series C funding to $87M to advance antibody engineering
Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British Business Bank, and GK Goh The funding will accelerate development of eProtein Discovery for full-format [...]
OutSee completes seed funding round and establishes partnership with o2h discovery for lead drug target candidate
Oversubscribed £2.5M seed round led by Ahren Innovation Capital Strategic collaboration with o2h to progress drug discovery programme Cambridge, UK, 12 January 2026: OutSee, a genomics and drug discovery company [...]
iXCells Biotechnologies appoints Steve Smith as CEO
Appointment strengthens leadership team as iXCells focuses on expanding its portfolio of custom-tailored iPSC products and delivery of enhanced preclinical services San Diego, CA, 12 January, 2026: iXCells Biotechnologies (“iXCells”), [...]
FairJourney Bio launches cryo-EM services with advanced laboratories in San Diego, USA
Expanded offering provides high-resolution structural insights to support antibody discovery and biologic design PORTO, Portugal, and SAN DIEGO, USA, 12 January 2026 – FairJourney Bio (FJBio), a leading global provider [...]
Qureight appoints Rebecca Simmons as Chief Operating Officer
Experienced operational leader across medical research and deep tech appointed to support sustainable growth as part of Qureight’s strategy to scale company operations Cambridge, UK, 12 January 2026 – Qureight, [...]
